Get 20% lifetime commission for referring investors to digrin.com
here.
Lyell Immunopharma, Inc. ( LYEL) - Stock Earnings
LYEL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 10, 2026, midnight | — / — | — | — / — | — |
LYEL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -140.7 million USD | 6000 USD |
| 2026Q1 | -24.2 million USD | 2000 USD |
| 2026Q2 | -44.8 million USD | 4000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
LYEL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -234.6 million USD | 130000 USD |
| 2024 | -343.0 million USD | 61000 USD |
| 2025 | -274.4 million USD | 36000 USD |
| 2026 Est. | — | — |
LYEL
Price: $8.12
52 week price:
Earnings Per Share: -12.69 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 208634
Market Capitalization: 213.7 million